Gender-specific dental health issues and treatment considerations

International Journal of Prosthodontics

Volumn 20, Issue 4, 2007, Pages 360-368

  Zitzmann, Nicola Ursula ^a   Schilling, Julian ^b   Weiger, Roland ^a   Pastoret, Marie Hélène ^a   Loretan, Pascal ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b Travel Clinic   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BONE DENSITY CONSERVATION AGENT; SEX HORMONE;

ARTICLE; DENTAL CARE; DEPRESSION; EATING DISORDER; FEMALE; HEALTH; HUMAN; MALE; MOUTH DISEASE; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; PSYCHOLOGICAL ASPECT; SEXUAL DEVELOPMENT; TEMPOROMANDIBULAR JOINT DISORDER; WOMEN'S HEALTH;

BONE DENSITY CONSERVATION AGENTS; DENTAL CARE; DEPRESSION; EATING DISORDERS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MOUTH DISEASES; ORAL HEALTH; OSTEOPOROSIS, POSTMENOPAUSAL; SEX CHARACTERISTICS; TEMPOROMANDIBULAR JOINT DISORDERS; WOMEN'S HEALTH;

EID: 34547628046     PISSN: 08932174     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (79)

1. Laine MA. Effect of pregnancy on periodontal and dental health. Acta Odontol Scand 2002;60:257-264.
2. Covington P. Women's oral health issues: An exploration of the literature. Probe 1996;30:173-177.
3. Freedman RJ. Reflections on beauty as it relates to health in adolescent females. Women Health 1984;9:29-45.
4. Hugoson A. Gingival inflammation and female sex hormones. A clinical investigation of pregnant women and experimental studies in dogs. J Periodontal Res Suppl 1970;5:1-18.
5. Sooriyamoorthy M, Gower DB. Hormonal influences on gingival tissue: Relationship to periodontal disease. J Clin Periodontol 1989;16:201-208.
6. Vittek J, Hernandez MR, Wenk EJ, Rappaport SC, Southren AL. Specific estrogen receptors in human gingiva. J Clin Endocrinol Metab 1982;54:608-612.
7. Laine M, Tenovuo J, Lehtonen OP, Ojanotko-Harri A, Vilja P, Tuohimaa P. Pregnancy-related changes in human whole saliva. Arch Oral Biol 1988;12:913-917.
8. Ojanotko-Harri A, Harri M-P, Hurttia H, Sewon L. Altered tissue metabolism of progesterone in pregnancy gingivitis and granuloma. J Clin Periodontol 1991;18:262-266.
9. Folkers SA, Weissmann DP. Periodontal disease in the life stages of women. Compend Contin Educ Dent 1993;13:852-860.
10. Albandar JM. Global risk factors and risk indicators for periodontal diseases. Periodontol 2000 2002;29:177-206.
11. Albandar JM, Rams TE. Risk factors for periodontitis in children and young persons. Periodontol 2000 2002;29:207-222.
12. Bobetsis YA, Barros SP, Offenbacher S. Exploring the relationship between periodontal disease and pregnancy complications. J Am Dent Assoc 2006;137 Suppl:7S-13S.
13. Offenbacher S, Lin D, Strauss R, et al. Effects of periodontal therapy during pregnancy on periodontal status, biologic parameters, and pregnancy outcomes: A pilot study. J Periodontol 2006;77:2011-2024.
14. Dickinson BD, Altman RD, Nielsen NH, Sterling ML. Drug interactions between oral contraceptives and antibiotics. Obstet Gynecol 2001;98:853-860.
15. Sreebny LM. Saliva in health and disease: An appraisal and update. Int Dent J 2000;50:140-161.
16. Tenovuo J, Lehtonen OP, Viikari J, Larjava H, Vilja P, Tuohimaa P. Immunoglobulins and innate antimicrobial factors in whole saliva of patients with insulin-dependent diabetes mellitus. J Dent Res 1986;65:62-66.
17. Navazesh M, Brightman VJ, Pogoda JM. Relationship of medical status, medications, and salivary flow rates in adults of different ages. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;81:172-176.
18. Ben-Aryeh H, Miron D, Berdicevsky I, Szargel R, Gutman D. Xerostomia in the elderly: Prevalence, diagnosis, complications and treatment. Gerodontology 1985;4:77-82.
19. Eguia Del Valle A, Aguirre-Urizar JM, Martinez-Conde R, Echebarria-Goikouria MA, Sagasta-Pujana O. Burning mouth syndrome in the Basque Country: A preliminary study of 30 cases. Med Oral 2003;8:84-90.
20. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino MA. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003;14:275-291.
21. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005:CD002779.
22. LeResche L, Saunders K, Von Korff MR, Barlow W, Dworkin SF. Use of exogenous hormones and risk of temporomandibular disorder pain. Pain 1997;69:153-160.
23. Warren MP, Fried JL. Temporomandibular disorders and hormones in women. Cells Tissues Organs 2001;169:187-192.
24. Graff-Radford SB, Solberg WK. Atypical odontalgia. J Craniomandib Disord 1992;6:260-265.
25. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985;7:178-208.
26. Faine MP. Dietary factors related to preservation of oral and skeletal bone mass in women. J Prosthet Dent 1995;73:65-72.
27. Consensus development conference: Diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646-650.
28. Nordin BE. The definition and diagnosis of osteoporosis. Calcif Tissue Int 1987;40:57-58.
29. von Wowern N, Klausen B, Kollerup G. Osteoporosis: A risk factor in periodontal disease. J Periodontol 1994;65:1134-1138.
30. von Wowern N. Bone mineral content of mandibles: Normal reference values - Rate of age related bone loss. Calcif Tissue Int 1988;43:193-198.
31. Christiansen C, Mazess RB, Transbol I, Jensen GF. Factors in response to treatment of early postmenopausal bone loss. Calcif Tissue Int 1981;33:575-581.
32. von Wowern N, Kollerup G. Symptomatic osteoporosis: A risk factor for residual ridge reduction of the jaws. J Prosthet Dent 1992;67:656-660.
33. Pan J, Shirota T, Ohno K, Michi K. Effect of ovariectomy on bone remodeling adjacent to hydroxyapatite-coated implants in the tibia of mature rats. J Oral Maxillofac Surg 2000;58:877-882.
34. Yamazaki M, Shirota T, Tokugawa Y, et al. Bone reactions to titanium screw implants in ovariectomized animals. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;87:411-418.
35. Nociti FH Jr, Sallum AW, Sallum EA, Duarte PM. Effect of estrogen replacement and calcitonin therapies on bone around titanium implants placed in ovariectomized rats: A histometric study. Int J Oral Maxillofac Implants 2002;17:786-792.
36. Shirai H, Sato T, Oka M, Hara T, Mori S. Effect of calcium supplementation on bone dynamics of the maxilla, mandible and proximal tibia in experimental osteoporosis. J Oral Rehabil 2002;29:287-294.
37. Friberg B, Ekestubbe A, Mellstrorn D, Sennerby L. Brånemark implants and osteoporosis: A clinical exploratory study. Clin Implant Dent Relat Res 2001;3:50-56.
38. Mori H, Manabe M, Kurachi Y, Nagumo M. Osseointegration of dental implants in rabbit bone with low mineral density. J Oral Maxillofac Surg 1997;55:351-361.
39. Minsk L, Poison AM. Dental implant outcomes in postmenopausal women undergoing hormone replacement. Compend Contin Educ Dent 1998;19:859-862.
40. Nightingale AL, Lawrenson RA, Simpson EL, Williams TJ, MacRae KD, Farmer RD. The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives. Eur J Contracept Reprod Health Care 2000;5:265-274.
41. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 1993;328:460-464.
42. Dawson-Hughes B, Dallai GE, Krall EA, Sadowski L, Sayhoun N, Tannenbaum S. A controlled clinical trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 1990;323:878-883.
43. Hodsman AB, Bauer DC, Dempster DW, et al. Parathyroid hormone and teriparatide for the treatment of osteoporosis: A review of the evidence and suggested guidelines for its use. Endocr Rev 2005;26:688-703.
44. Massler M. Geriatric nutrition. I: Osteoporosis. J Prosthet Dent 1979;42:252-254.
45. Jehle S, Zanetti A, Muser J, Hulter HN, Krapf R. Partial neutralization of the acidogenic Western diet with potassium citrate increases bone mass in postmenopausal women with osteopenia. J Am Soc Nephrol 2006;17:3213-3222.
46. Kribbs PJ. Two-year changes in mandibular bone mass in an osteoporotic population. J Prosthet Dent 1992;67:653-655.
47. D'Ambrosia RD. Epidemiology of osteoarthritis. Orthopedics 2005;28:s201-205.
48. Sowers M. Epidemiology of risk factors for osteoarthritis: Systemic factors. Curr Opin Rheumatol 2001;13:447-451.
49. Srikanth VK, Fryer JL, Zhai G, Winzenberg TM, Hosmer D, Jones G. A meta-analysis of sex differences prevalence, incidence and severity of osteoarthritis. Osteoarthritis Cartilage 2005;13:769-781.
50. Petersson IF, Jacobsson LT. Osteoarthritis of the peripheral joints. Best Pract Res Clin Rheumatol 2002;16:741-760.
51. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis 2002;61 Suppl 2:ii84-86.
52. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002;46:328-346, www.rheumatology. org/publications/guidelines.
53. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
54. Diel IJ, Body JJ, Lichinitser MR, et al. Improved quality of life for long-term treatment with the bisphosphonate ibandronate in patients with metastatic bone disease due to breast cancer. Eur J Cancer 2004;40:1704-1712.
55. Lin JH, Russell G, Gertz B. Pharmacokinetics of alendronate: An overview. J Clin Pract Suppl 1999;101:18-26.
56. Jee WS, Tang L, Ke HZ, Setterberg RB, Kimmel DB. Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: dynamic histomorphometry of changes in bone mass. Bone 1993;14:493-498.
57. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg 2005;63:1567-1575.
58. Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report. Int J Oral Maxillofac Implants 1995;10:74-78.
59. Jeffcoat MK. Safety of oral bisphosphonates: Controlled studies on alveolar bone. Int J Oral Maxillofac Implants 2006;21:349-353.
60. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: Bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006;144:753-761.
61. Bagan JV, Jimenez Y, Murillo J, et al. Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 2006;42:327-329.
62. Bamias A, Kastritis E, Bamia C, et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors. J Clin Oncol 2005;23:8580-8587.
63. Report of the Council on Scientific Affairs. Dental Management of Patients Receiving Oral Bisphosphonates Therapy-Expert Panel Recommendations. American Dental Association, 2006.
64. Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P. Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis. Int J Oral Maxillofac Implants 2007;22:146-153.
65. Joossens L. Effective tobacco control policies in 28 European countries. European Network for Smoking Prevention 2004. Available at: www.ensp.org/ publications/ensreports. Accessed June 2006.
66. Hudson JI, Hiripi E, Pope HG Jr, Kessler RC. The prevalence and correlates of eating disorders in the national comorbidity survey replication. Biol Psychiatry 2007;61:348-358.
67. Keel PK, Heatherton TF, Dorer DJ, Joiner TE, Zalta AK. Point prevalence of bulimia nervosa in 1982, 1992, and 2002. Psychol Med 2006;36:119-127.
68. Nelson WL, Hughes HM, Katz B, Searight HR. Anorexic eating attitudes and behaviors of male and female college students. Adolescence 1999;34:621-633.
69. Tozzi F, Thornton LM, Klump KL, et al. Symptom fluctuation in eating disorders: Correlates of diagnostic crossover. Am J Psychiatry 2005;162:732-740.
70. Debate RD, Vogel E, Tedesco LA, Neff JA. Sex differences among dentists regarding eating disorders and secondary prevention practices. J Am Dent Assoc 2006;137:773-781.
71. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
72. Sagud M, Hotujac L, Mihaljevic-Peles A, Jakovljevic M. Gender differences in depression. Coll Antropol 2002;26:149-157.
73. Sloan DM, Kornstein SG. Gender differences in depression and response to antidepressant treatment. Psychiatr Clin North Am 2003;26:581-594.
74. Zitzmann NU. Prosthetic Treatment of the Edentulous Patient with Particular Consideration Given to Implant-Supported Restorations [In German] [Habilitation thesis]. Basel: University of Basel, 2004.
75. Willumsen T. Dental fear in sexually abused women. Eur J Oral Sci 2001;109:291-296.
76. Zitzmann NU, Staehelin K, Walls AWG, Menghini G, Zemp Stutz E. Oral health and dental restorations in Switzerland. J Public Health Dent (in press).
77. Albrektsson T, Blomberg S, Brånemark A, Carlsson GE. Edentulousness - An oral handicap. Patient reactions to treatment with jawbone-anchored prostheses. J Oral Rehabil 1987;14:503-511.
78. Bergendal B. The relative importance of tooth loss and denture wearing in Swedish adults. Community Dent Health 1989;6:103-111.
79. McGrath C, Bedi R. Gender variations in the social impact of oral health. J Ir Dent Assoc 2000;46:87-91.